Table 1.

Patients’ characteristics.

MeasureAll patients, n = 32 (100 %)Monza patients, n = 20 (62.5%)Other hospitals’ patients, n = 12 (37.5%)
Patients mean age at diagnosis (years)45.13 (SD 7.69)46.55 (SD 8.67)42.75 (SD 5.17)
Patients gender
 Male15 (46.88%)10 (50%)5 (41.67%)
 Female17 (53.15%)10 (50%)7 (58.33%)
Patients nationality
 Italian29 (90.63%)19 (95%)10 (83.33%)
 Bulgarian1 (3.13%)0 (0%)1 (8.33%)
 Romanian1 (3.13%)1 (5%)0 (0%)
 Venezuelan1 (3.13%)0 (0%)1 (8.33%)
Children mean age (years)
 1 child11.15 (SD 4.87)12.21 (SD 4.3)9.92 (SD 5.38)
 2 child7.13 (SD 3.38)7.1 (SD 2.85)7.2 (SD 4.66)
 3 child2 (SD 0)2 (SD 0)
Hospital
 Monza20 (62.50%)20 (100%)0 (0%)
 Other hospitals12 (37.50%)0 (0%)12 (100%)
Duration of hospitalization (days)30.26 (SD 18.8)31.16 (SD 23.7)28.83 (SD 6.41)
Diagnosis
 SAA2 (6.25%)2 (10%)0 (0%)
 ALL4 (12.5%)1 (5%)3 (25%)
 AML15 (46.88%)10 (50%)5 (41.67%)
 CML1 (3.13%)0 (0%)1 (8.33%)
 NHL7 (21.88%)5 (25%)2 (16.67%)
 MM3 (9.38%)2 (10%)1 (8.33)
MeasureAll patients, n = 32 (100 %)Monza patients, n = 20 (62.5%)Other hospitals’ patients, n = 12 (37.5%)
Patients mean age at diagnosis (years)45.13 (SD 7.69)46.55 (SD 8.67)42.75 (SD 5.17)
Patients gender
 Male15 (46.88%)10 (50%)5 (41.67%)
 Female17 (53.15%)10 (50%)7 (58.33%)
Patients nationality
 Italian29 (90.63%)19 (95%)10 (83.33%)
 Bulgarian1 (3.13%)0 (0%)1 (8.33%)
 Romanian1 (3.13%)1 (5%)0 (0%)
 Venezuelan1 (3.13%)0 (0%)1 (8.33%)
Children mean age (years)
 1 child11.15 (SD 4.87)12.21 (SD 4.3)9.92 (SD 5.38)
 2 child7.13 (SD 3.38)7.1 (SD 2.85)7.2 (SD 4.66)
 3 child2 (SD 0)2 (SD 0)
Hospital
 Monza20 (62.50%)20 (100%)0 (0%)
 Other hospitals12 (37.50%)0 (0%)12 (100%)
Duration of hospitalization (days)30.26 (SD 18.8)31.16 (SD 23.7)28.83 (SD 6.41)
Diagnosis
 SAA2 (6.25%)2 (10%)0 (0%)
 ALL4 (12.5%)1 (5%)3 (25%)
 AML15 (46.88%)10 (50%)5 (41.67%)
 CML1 (3.13%)0 (0%)1 (8.33%)
 NHL7 (21.88%)5 (25%)2 (16.67%)
 MM3 (9.38%)2 (10%)1 (8.33)

Abbreviations: SAA, severe aplastic anemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; NHL, non-Hodgkin lymphoma; MM, multiple myeloma.

Table 1.

Patients’ characteristics.

MeasureAll patients, n = 32 (100 %)Monza patients, n = 20 (62.5%)Other hospitals’ patients, n = 12 (37.5%)
Patients mean age at diagnosis (years)45.13 (SD 7.69)46.55 (SD 8.67)42.75 (SD 5.17)
Patients gender
 Male15 (46.88%)10 (50%)5 (41.67%)
 Female17 (53.15%)10 (50%)7 (58.33%)
Patients nationality
 Italian29 (90.63%)19 (95%)10 (83.33%)
 Bulgarian1 (3.13%)0 (0%)1 (8.33%)
 Romanian1 (3.13%)1 (5%)0 (0%)
 Venezuelan1 (3.13%)0 (0%)1 (8.33%)
Children mean age (years)
 1 child11.15 (SD 4.87)12.21 (SD 4.3)9.92 (SD 5.38)
 2 child7.13 (SD 3.38)7.1 (SD 2.85)7.2 (SD 4.66)
 3 child2 (SD 0)2 (SD 0)
Hospital
 Monza20 (62.50%)20 (100%)0 (0%)
 Other hospitals12 (37.50%)0 (0%)12 (100%)
Duration of hospitalization (days)30.26 (SD 18.8)31.16 (SD 23.7)28.83 (SD 6.41)
Diagnosis
 SAA2 (6.25%)2 (10%)0 (0%)
 ALL4 (12.5%)1 (5%)3 (25%)
 AML15 (46.88%)10 (50%)5 (41.67%)
 CML1 (3.13%)0 (0%)1 (8.33%)
 NHL7 (21.88%)5 (25%)2 (16.67%)
 MM3 (9.38%)2 (10%)1 (8.33)
MeasureAll patients, n = 32 (100 %)Monza patients, n = 20 (62.5%)Other hospitals’ patients, n = 12 (37.5%)
Patients mean age at diagnosis (years)45.13 (SD 7.69)46.55 (SD 8.67)42.75 (SD 5.17)
Patients gender
 Male15 (46.88%)10 (50%)5 (41.67%)
 Female17 (53.15%)10 (50%)7 (58.33%)
Patients nationality
 Italian29 (90.63%)19 (95%)10 (83.33%)
 Bulgarian1 (3.13%)0 (0%)1 (8.33%)
 Romanian1 (3.13%)1 (5%)0 (0%)
 Venezuelan1 (3.13%)0 (0%)1 (8.33%)
Children mean age (years)
 1 child11.15 (SD 4.87)12.21 (SD 4.3)9.92 (SD 5.38)
 2 child7.13 (SD 3.38)7.1 (SD 2.85)7.2 (SD 4.66)
 3 child2 (SD 0)2 (SD 0)
Hospital
 Monza20 (62.50%)20 (100%)0 (0%)
 Other hospitals12 (37.50%)0 (0%)12 (100%)
Duration of hospitalization (days)30.26 (SD 18.8)31.16 (SD 23.7)28.83 (SD 6.41)
Diagnosis
 SAA2 (6.25%)2 (10%)0 (0%)
 ALL4 (12.5%)1 (5%)3 (25%)
 AML15 (46.88%)10 (50%)5 (41.67%)
 CML1 (3.13%)0 (0%)1 (8.33%)
 NHL7 (21.88%)5 (25%)2 (16.67%)
 MM3 (9.38%)2 (10%)1 (8.33)

Abbreviations: SAA, severe aplastic anemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; NHL, non-Hodgkin lymphoma; MM, multiple myeloma.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close